Efficacy and safety of ceftazidime/avibactam in patients with infections caused by ß-lactamase-producing Gram-negative pathogens: a pooled analysis from the Phase 3 clinical trial programme.
J Antimicrob Chemother
; 78(11): 2672-2682, 2023 11 06.
Article
in En
| MEDLINE
| ID: mdl-37700689
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Urinary Tract Infections
/
Intraabdominal Infections
Type of study:
Clinical_trials
Limits:
Adult
/
Humans
Language:
En
Journal:
J Antimicrob Chemother
Year:
2023
Document type:
Article
Affiliation country:
España
Country of publication:
Reino Unido